Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:LJPC’

Broadfin Kevin Kotler

Is La Jolla Pharmaceutical Company (LJPC) Going to Burn These Hedge Funds?

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first...

Keep Reading →

June 10 - Hedge Funds, News - Comments

Felix Baker - Baker Bros.

Is La Jolla Pharmaceutical Company (LJPC) A Good Stock To Buy?

The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with...

Keep Reading →

December 13 - Hedge Funds, News - Comments

Michael Castor Sio Capital

La Jolla Pharmaceutical Company (LJPC): Hedge Funds In Wait-and-See Mode

The financial regulations require hedge funds and wealthy investors that crossed the $100 million equity holdings threshold to file a report that shows...

Keep Reading →

November 11 - Hedge Funds, News - Comments

bank, banking, business, businessman, cash, cellphone, concept, corporate, currency, dollar, euro, financial, forex, horizontal, illustration, internet, invest, investing, investor, job, market, marketplace, men, money, network, office, phone, remotely, smart, smartphone, stock, suit, to go, touchscreen, trade, trader, trading, work, worker, working

Hedge Fund and Insider Trading News: Carl Icahn, Crispin Odey, ValueAct Capital, La Jolla Pharmaceutical (LJPC), New Mountain Finance Corp. (NMFC), and More

Carl Icahn Builds Stake in Caesars Entertainment: Sources (CNBC) Billionaire activist investor Carl Icahn is building a stake in casino company Caesars...

Keep Reading →

January 11 - Hedge Funds, Insider Trading - Comments

Broadfin Kevin Kotler

Hedge Funds Are Crazy About La Jolla Pharmaceutical Company (LJPC)

There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating...

Keep Reading →

December 22 - Hedge Funds, News - Comments

trade, forex, investment, gain, stock, phone, network, view, report, money, smart, background, broker, market, laptop, table, economy, display, loss, business, urban,

Hedge Fund and Insider Trading News: Starboard Value LP, York Capital Management, Prospect Capital Corporation (PSEC), CytomX Therapeutics Inc (CTMX), Ichor Holdings Ltd (ICHR), and More

Starboard’s Newell Board Nominees Retreat After Icahn Swoop (Reuters) (Reuters) – Four of Starboard Value’s nominees to Newell Brands Inc...

Keep Reading →

March 20 - Hedge Funds, Insider Trading - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: Tang Capital Partners LP and La Jolla Pharmaceutical Co (LJPC)

La Jolla Pharmaceutical Co (NASDAQ:LJPC): Kevin C. Tang’s Tang Capital Partners LP filed an amended 13D. You can check out Tang Capital Partners...

Keep Reading →

March 20 - Hedge Funds - Comments

13D Filing: Tang Capital Partners LP and La Jolla Pharmaceutical Co (LJPC)

La Jolla Pharmaceutical Co (NASDAQ:LJPC): Kevin C. Tang’s Tang Capital Partners LP filed an amended 13D. You can check out Tang Capital Partners...

Keep Reading →

March 2 - Hedge Funds - Comments

easiest countries to get oxycodone prescribed

13G Filing: Perceptive Advisors and La Jolla Pharmaceutical Co (LJPC)

La Jolla Pharmaceutical Co (NASDAQ:LJPC): Joseph Edelman’s Perceptive Advisors filed an amended 13D. You can check out Perceptive Advisors’...

Keep Reading →

December 18 - Hedge Funds - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, internet, male, drugstore, service,

Hedge Funds Are Betting On La Jolla Pharmaceutical Company (LJPC)

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment...

Keep Reading →

December 12 - Hedge Funds, News - Comments

Jacob Gottlieb - Visium Asset Management

13G Filing: Visium Asset Management Has Nearly Doubled Its Stake in La Jolla Pharmaceutical Co (LJPC)

We are seeing a boatload of 13G filing activity at the moment and investment firms disclose their positions as of the end of 2015 (we are not publishing...

Keep Reading →

February 12 - Hedge Funds, News - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Is La Jolla Pharmaceutical Company (LJPC) A Good Stock To Buy?

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the...

Keep Reading →

December 14 - Hedge Funds, News - Comments

Why MeetMe Inc (MEET), La Jolla Pharmaceutical Co. (LJPC), & Sorrento Therapeutics Inc (SRNE) Surged Last Week

MeetMe Inc (NASDAQ:MEET), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), and Sorrento Therapeutics Inc (NASDAQ:SRNE) experienced a formidable surge on the...

Keep Reading →

June 29 - Hedge Funds, Market Movers, News - Comments

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

Heron Therapeutics Inc (HRTX), La Jolla Pharmaceutical Company (LJPC), Salix Pharmaceuticals, Ltd. (SLXP) Are Tang Capital’s Largest Bets in Q4

Kevin Tang‘s Tang Capital Partners is one of the funds that have already revealed their equity portfolios as of the end of last year. The healthcare...

Keep Reading →

January 29 - Hedge Funds, News - Comments

Broadfin Kevin Kotler

Broadfin Capital Initiates New Positions In Corium International Inc (CORI), AMAG Pharmaceuticals Inc. (AMAG) and La Jolla Pharmaceutical Company (LJPC)

In three recent filings, Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals...

Keep Reading →

April 17 - Hedge Funds, News - Comments